PIERS calculator- predicting adverse maternal outcome in preeclampsia
DOI:
https://doi.org/10.18203/2320-1770.ijrcog20170889Keywords:
Maternal outcome, PIERS calculator, PreeclampsiaAbstract
Background: Preeclampsia is a multisystem, highly variable disorder unique to pregnancy. For preeclampsia arising remote from term, supportive and temporizing measures are used to improve perinatal outcome. However, the magnitude of the maternal risks associated with expectant management is unclear. The PIER (preeclampsia integrated estimate of risk) score is a recently designed tool which assesses maternal signs, symptoms, and laboratory findings to generate a valid and reliable algorithm for predicting maternal and perinatal outcome in patients with preeclampsia.
Methods: The present study was a prospective hospital based observational study carried out in Department of Obstetrics and Gynecology, Sultania Zanana Hospital, Gandhi Medical College, Bhopal. A total of 125 women with preeclampsia who fulfilled the inclusion criteria were included in the study. Along with history and examination, all relevant and required investigations were done. The fullPIERS calculator was used to calculate the risk of adverse maternal outcome.
Results: In the present study, 82(65.6%) women were in the low risk category and only 4 (4.87%) had adverse maternal outcome. High risk patients were 6 (4.8%) and amongst them 5 (83.33%) women had adverse maternal outcome (p-value <0.00001). The result was statistically significant in identifying high risk cases in our study.
Conclusions: The fullPIERS calculator gave good results in prediction of adverse maternal outcome according to risk score in women with preeclampsia in our study. It will help the clinicians better manage the patients with preeclampsia specially remote from term and also help health workers in primary and secondary care centres to identify women who are or may become severely ill and who need specialist care and prevent delays in transporting these women to facilities where they can receive appropriate care.
References
Hutcheon JA, Lisonkova S, Joseph KS. Epidemiology of pre-eclampsia and the other hypertensive disorders of pregnancy. Best Pract Res Clin Obstet Gynaecol. 2011;25(4):391-403.
World Health Organization. The world health report: 2005: make every mother and child count. Geneva: WHO;2005.
Duley L. Maternal mortality associated with hypertensive disorders of pregnancy in Africa, Asia, Latin America and the Caribbean. Br J Obstet Gynaecol. 1992;99:547-53.
Duckitt K, Harrington D. Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies. BMJ. 2005;330(7491):565
Steegers EAP, von Dadelszen P, Duvekot JJ, Pijnenborg R. Pre-eclampsia. Lancet. 2010;376:631-44.
von Dadelszen P, Payne B, Li J, Ansermino JM, Broughton Pipkin F, Cote AM, et al. Prediction of adverse maternal outcomes in pre-eclampsia: development and validation of the fullPIERS model. Lancet.2011;377:219-27.
Martin JN Jr, May WL, Magann EF, Terrone DA, Rinehart BK, Blake PG. Early risk assessment of severe preeclampsia: admission battery of symptoms and laboratory tests to predict likelihood of subsequent significant maternal morbidity. Am J Obstet Gynecol. 1999;180:1407–14.
Cavkaytar S, Ugurlu EN, Karaer A, Tapisiz OL, Danisman N. Are clinical symptoms more predictive than laboratory parameters for adverse maternal outcome in HELLP syndrome? Acta Obstet Gynecol Scand. 2007;86:648-51.
Yen TW, Payne B, Qu Z, Hutcheon JA, Lee T, Magee LA, Walters BN, von Dadelszen P. Using clinical symptoms to predict adverse maternal and perinatal outcomes in women with preeclampsia: data from the PIERS (pre-eclampsia integrated estimate of risk) study. J Obstet Gynaecol Can. 2011;33(8):803-9
Gaugler-Senden IP, Huijssoon AG, Visser W, Steegers EA, de Groot CJ. Maternal and perinatal outcome of preeclampsia with an onset before 24 weeks' gestation. Audit in a tertiary referral center. Eur J Obstet Gynecol Reprod Biol. 2006;128(1-2):216-21.
Ni Y, Cheng W. Comparison of indications of pregnancy termination and prognosis of mothers and neonates in early- and late-onset preeclampsia. Hypertension in Pregnancy. 2016;35:3.
Millman AL, Payne B, Qu Z, Douglas MJ, Hutcheon JA, Lee T, Magee LA, Walley KR, von Dadelszen P. Oxygen saturation as a predictor of adverse maternal outcomes in women with preeclampsia. J Obstet Gynaecol Can. 2011;33(6):705-14
Agrawal S, Maitra N. Prediction of adverse maternal outcomes in preeclampsia using a risk prediction model. J Obstet Gynecol India. 2016;66(1):104-11.
Thangaratinam S, Koopmans CM, Iyengar S, Zamora J, Ismail KM, Mol BW, Khan KS. TIPPS (Tests in Prediction of Preeclampsia's Severity) Review Group Accuracy of liver function tests for predicting adverse maternal and fetal outcomes in women with preeclampsia: a systematic review. Acta Obstet Gynecol Scand. 2011;90(6):574-85.
B Payne, S Hodgson, JA Hutcheon, KS Joseph, J Li, T Lee, LA Magee, Z Qu, P von Dadelszen. Performance of the fullPIERS model in predicting adverse maternal outcomes in pre-eclampsia using patient data from the PIERS (Pre-eclampsia Integrated Estimate of RiSk) cohort, collected on admission. BOJS. 2013;120:113-8.
